In vivo near-infrared imaging of fibrin deposition in thromboembolic stroke in mice

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Zhang, Yi ^a   Fan, Shufeng ^a   Yao, Yuyu ^a   Ding, Jie ^a   Wang, Yu ^a   Zhao, Zhen ^a   Liao, Lei ^a   Li, Peicheng ^a   Zang, Fengchao ^a   Teng, Gao Jun ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13A; FIBRIN; ACETYL GLYCYL ASPARAGYL GLUTAMINYL GLUTAMYL GLUTAMINYL VALYL SERYL PROLYL LEUCYL THREONYL LEUCYL LEUCYL LYSYL LYSYL TRYPTOPHYL CYSTEINYL ALEXA FLUORO 680 C2C2 MALEIMIDE CONJUGATE; ACETYL-GLYCYL-ASPARAGYL-GLUTAMINYL-GLUTAMYL-GLUTAMINYL-VALYL-SERYL-PROLYL-LEUCYL-THREONYL-LEUCYL-LEUCYL-LYSYL-LYSYL-TRYPTOPHYL-CYSTEINYL-ALEXA FLUORO 680 C2C2-MALEIMIDE CONJUGATE; ALPHA 2 ANTIPLASMIN; DIAGNOSTIC AGENT; FLUORESCENT DYE; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; FIBRIN DEPOSITION; FLUORESCENCE MICROSCOPY; HEMISPHERE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULAR IMAGING; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; SIGNAL TRANSDUCTION; STROKE; THROMBOEMBOLISM; THROMBOSIS; ANIMAL; BRAIN; C57BL MOUSE; CHEMISTRY; FEASIBILITY STUDY; METABOLISM; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY; TIME;

ANIMALIA; MUS;

ALPHA-2-ANTIPLASMIN; ANIMALS; BRAIN; FACTOR XIIIA; FEASIBILITY STUDIES; FIBRIN; FLUORESCENT DYES; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; SPECTROSCOPY, NEAR-INFRARED; STROKE; THROMBOEMBOLISM; TIME FACTORS;

EID: 84855862357     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030262     Document Type: Article

References (31)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, et al. (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123: e18-e209.
2. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, et al. (2006) The lifetime risk of stroke: estimates from the Framingham Study. Stroke 37: 345-350.
3. Durukan A, Tatlisumak T, (2007) Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87: 179-197.
4. Zhang RL, Chopp M, Zhang ZG, Jiang Q, Ewing JR, (1997) A rat model of focal embolic cerebral ischemia. Brain Res 766: 83-92.
5. Albers GW, (1995) Antithrombotic agents in cerebral ischemia. Am J Cardiol 75: 34B-38B.
6. Klohs J, Grafe M, Graf K, Steinbrink J, Dietrich T, et al. (2008) In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody. Stroke 39: 2845-2852.
7. Klohs J, Baeva N, Steinbrink J, Bourayou R, Boettcher C, et al. (2009) In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia. J Cereb Blood Flow Metab 29: 1284-1292.
8. Hilderbrand SA, Weissleder R, (2010) Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 14: 71-79.
9. van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, et al. (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med 17: 1315-1319.
10. Kasahara K, Souri M, Kaneda M, Miki T, Yamamoto N, et al. (2010) Impaired clot retraction in factor XIII A subunit-deficient mice. Blood 115: 1277-1279.
11. Jaffer FA, Tung CH, Wykrzykowska JJ, Ho NH, Houng AK, et al. (2004) Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 110: 170-176.
12. Tung CH, Ho NH, Zeng Q, Tang Y, Jaffer FA, et al. (2003) Novel factor XIII probes for blood coagulation imaging. Chembiochem 4: 897-899.
13. Kim DE, Schellingerhout D, Jaffer FA, Weissleder R, Tung CH, (2005) Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab 25: 226-233.
14. Siebler M, Nachtmann A, Sitzer M, Steinmetz H, (1994) Anticoagulation monitoring and cerebral microemboli detection. Lancet 344: 555.
15. Heye N, Cervos-Navarro J, (1996) Microthromboemboli in acute infarcts: analysis of 40 autopsy cases. Stroke 27: 431-434.
16. Zhang ZG, Chopp M, Goussev A, Lu D, Morris D, et al. (1999) Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats. J Neurosci 19: 10898-10907.
17. Wang L, Kittaka M, Sun N, Schreiber SS, Zlokovic BV, (1997) Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats. J Cereb Blood Flow Metab 17: 136-146.
18. Tabrizi P, Wang L, Seeds N, McComb JG, Yamada S, et al. (1999) Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol 19: 2801-2806.
19. Mosesson MW, Siebenlist KR, Meh DA, (2001) The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 936: 11-30.
20. Klohs J, Steinbrink J, Nierhaus T, Bourayou R, Lindauer U, et al. (2006) Noninvasive near-infrared imaging of fluorochromes within the brain of live mice: an in vivo phantom study. Mol Imaging 5: 180-187.
21. Okada Y, Copeland BR, Fitridge R, Koziol JA, del Zoppo GJ, (1994) Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 25: 1847-1853; discussion 1853-1844.
22. Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, et al. (2004) Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke 35: 566-571.
23. Hara T, Mies G, Hossmann KA, (2000) Effect of thrombolysis on the dynamics of infarct evolution after clot embolism of middle cerebral artery in mice. J Cereb Blood Flow Metab 20: 1483-1491.
24. Ariens RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ, (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100: 743-754.
25. Muszbek L, Bagoly Z, Bereczky Z, Katona E, (2008) The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis. Cardiovasc Hematol Agents Med Chem 6: 190-205.
26. Muszbek L, Bereczky Z, Bagoly Z, Komaromi I, Katona E, (2011) Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 91: 931-972.
27. Miserus RJ, Herias MV, Prinzen L, Lobbes MB, Van Suylen RJ, et al. (2009) Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent. JACC Cardiovasc Imaging 2: 987-996.
28. Uppal R, Ay I, Dai G, Kim YR, Sorensen AG, et al. (2010) Molecular MRI of intracranial thrombus in a rat ischemic stroke model. Stroke 41: 1271-1277.
29. Adams RA, Passino M, Sachs BD, Nuriel T, Akassoglou K, (2004) Fibrin mechanisms and functions in nervous system pathology. Mol Interv 4: 163-176.
30. Ryu JK, Davalos D, Akassoglou K, (2009) Fibrinogen signal transduction in the nervous system. J Thromb Haemost 7 (Suppl 1): 151-154.
31. Kilic E, Hermann DM, Hossmann KA, (1998) A reproducible model of thromboembolic stroke in mice. Neuroreport 9: 2967-2970.